BR112016007057A2 - um método veterinário para induzir êmese - Google Patents

um método veterinário para induzir êmese

Info

Publication number
BR112016007057A2
BR112016007057A2 BR112016007057A BR112016007057A BR112016007057A2 BR 112016007057 A2 BR112016007057 A2 BR 112016007057A2 BR 112016007057 A BR112016007057 A BR 112016007057A BR 112016007057 A BR112016007057 A BR 112016007057A BR 112016007057 A2 BR112016007057 A2 BR 112016007057A2
Authority
BR
Brazil
Prior art keywords
emesis
animal
veterinary
induce emesis
situations
Prior art date
Application number
BR112016007057A
Other languages
English (en)
Other versions
BR112016007057B1 (pt
Inventor
Kokkonen Johanna
Levijoki Jouko
Saloranta Lasse
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of BR112016007057A2 publication Critical patent/BR112016007057A2/pt
Publication of BR112016007057B1 publication Critical patent/BR112016007057B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

resumo “um método veterinário para induzir êmese” a invenção refere-se a um método de induzir êmese em animais, particu-larmente animais de companhia tais como cães e gatos, em situações onde vômito é desejado. o método compreende administrar uma composição de colírio compreen-dendo um agonista de dopamina da família de d2 seletivo como um ingrediente ati-vo ao olho do animal para induzir êmese. o método e a composição são úteis em situações envolvendo ingestão de uma substância potencialmente tóxica ou corpo estranho pelo animal.
BR112016007057-7A 2013-09-30 2014-09-29 Uso de uma composição de colírio compreendendo ropinirol para indução de êmese em cão BR112016007057B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361884924P 2013-09-30 2013-09-30
US61/884,924 2013-09-30
PCT/FI2014/000022 WO2015044504A1 (en) 2013-09-30 2014-09-29 A veterinary method for inducing emesis

Publications (2)

Publication Number Publication Date
BR112016007057A2 true BR112016007057A2 (pt) 2017-08-01
BR112016007057B1 BR112016007057B1 (pt) 2023-04-11

Family

ID=51845431

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016007057-7A BR112016007057B1 (pt) 2013-09-30 2014-09-29 Uso de uma composição de colírio compreendendo ropinirol para indução de êmese em cão

Country Status (21)

Country Link
US (1) US10092510B2 (pt)
EP (1) EP3052194B1 (pt)
JP (1) JP6382993B2 (pt)
KR (1) KR102277168B1 (pt)
CN (1) CN105592889B (pt)
AU (1) AU2014326576B2 (pt)
BR (1) BR112016007057B1 (pt)
CA (1) CA2922913C (pt)
DK (1) DK3052194T3 (pt)
ES (1) ES2878146T3 (pt)
HR (1) HRP20211308T1 (pt)
HU (1) HUE056109T2 (pt)
LT (1) LT3052194T (pt)
MX (1) MX370302B (pt)
NZ (1) NZ717434A (pt)
PL (1) PL3052194T3 (pt)
PT (1) PT3052194T (pt)
RU (1) RU2693492C2 (pt)
SI (1) SI3052194T1 (pt)
WO (1) WO2015044504A1 (pt)
ZA (1) ZA201601468B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3737378T1 (sl) * 2018-01-12 2023-06-30 Orion Corporation Kapljice palonosetrona za oči za zdravljenje ali preprečevanje slabosti in bruhanja
SI4099980T1 (sl) 2020-02-03 2024-03-29 Orion Corporation Stabilni farmacevtski sestavki ropinirola

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336490C (en) * 1988-06-03 1995-08-01 Paul Michael Iuvone Pharmacological treatment of ocular development
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
CN101678006A (zh) * 2007-05-11 2010-03-24 参天制药株式会社 含有非麦角类的选择性d2受体激动剂作为有效成分的后眼部疾病的预防或治疗剂

Also Published As

Publication number Publication date
EP3052194B1 (en) 2021-06-16
US20160206555A1 (en) 2016-07-21
US10092510B2 (en) 2018-10-09
JP2016531940A (ja) 2016-10-13
JP6382993B2 (ja) 2018-08-29
MX2016003904A (es) 2016-06-17
LT3052194T (lt) 2021-07-12
RU2016116810A3 (pt) 2018-07-02
RU2693492C2 (ru) 2019-07-03
BR112016007057B1 (pt) 2023-04-11
AU2014326576A1 (en) 2016-03-17
ES2878146T3 (es) 2021-11-18
HRP20211308T1 (hr) 2021-11-26
PT3052194T (pt) 2021-07-06
AU2014326576B2 (en) 2019-03-14
SI3052194T1 (sl) 2021-09-30
KR20160062130A (ko) 2016-06-01
HUE056109T2 (hu) 2022-01-28
CA2922913C (en) 2021-09-07
DK3052194T3 (da) 2021-07-26
NZ717434A (en) 2019-03-29
KR102277168B1 (ko) 2021-07-15
ZA201601468B (en) 2017-06-28
CN105592889B (zh) 2019-06-21
CN105592889A (zh) 2016-05-18
EP3052194A1 (en) 2016-08-10
WO2015044504A1 (en) 2015-04-02
MX370302B (es) 2019-12-09
PL3052194T3 (pl) 2021-12-13
CA2922913A1 (en) 2015-04-02
RU2016116810A (ru) 2017-11-10

Similar Documents

Publication Publication Date Title
CL2020000739A1 (es) Agente prolongado de control de ectoparasito para animales.
CL2014002087A1 (es) Composición veterinaria masticable que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal.
MX2017005721A (es) Composicion veterinaria masticable agradable al paladar.
GT201000160A (es) Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales
CL2012003180A1 (es) Mezcla de plaguicidas; composicion plaguicisa que comprende dicha mezcla; metodo para controlar plagas de animales y/o mejorar la salud de las plantas; material de propagación vegetal; uso de la mezcla para controlar plagas en animales.
BR112018006048A2 (pt) drone agrícola para o uso no monitoramento de gado
CL2012002770A1 (es) Compuestos derivados de 3,5-difenil-5-trifluoro-isoxazolina sustituidos; composición veterinaria; y su uso como ectoparasiticidas para tratar una infección e infestación por ácaros e insectos en animales y pájaros.
PH12015501891A1 (en) Novel bacteriophage and antibacterial composition comprising the same
BR112012010689B8 (pt) mistura antifúngica com organismo fúngico
PH12016502003A1 (en) Novel bacteriophage and composition containing same
PH12015501890A1 (en) Novel bacteriophage and antibacterial composition comprising the same
MX2015015941A (es) Composiciones ingeribles que contienen componente de aguacate criollo.
BR112015023025A2 (pt) composições antimicrobianas e métodos de uso relacionados
BR112016000869A2 (pt) compostos, composição agrícola, composição veterinária, usos de um composto, método para controlar pragas de invertebrados, composição e método para tratar ou proteger um animal
PH12016502573A1 (en) Use of active compound compositions
BR112016007057A2 (pt) um método veterinário para induzir êmese
EA201590596A1 (ru) Порошковая композиция для дезинфекции сосков молочных животных
CR20150508A (es) Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles
IN2014DN05976A (pt)
TR201908936T4 (tr) Opioidler ile kombinasyon halinde palmitoiletanolamid kullanımı.
BR112019003890A2 (pt) uso de oligossacarídeos de leite humano em engordamento de bezerros
EA201590097A1 (ru) Составы с однократной дозой для перорального введения и способы лечения кошек с помощью спиносада, уничтожающего эктопаразитов
GB2550750A (en) Anthelmintic compounds
CL2011002901A1 (es) Composicion veterinaria inyectable de liberacion prolongada y dosis unica que comprende microparticulas de polihidroxibutirato co-3-hidroxivalerato (phbv), un agente antimicrobiano seleccionado de ceftiofur o florfenicol y agua para inyeccion; procedimiento de preparacion; util para tratar infecciones en animales.
UA108238C2 (xx) Антибактеріальна композиція

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/09/2014, OBSERVADAS AS CONDICOES LEGAIS